| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
|
| | Begelomab Basic information |
| Product Name: | Begelomab | | Synonyms: | Begelomab;Research Grade Begelomab (DHD74101);Research Grade Begelomab;Begelomab (anti-DPP4) | | CAS: | 1403744-56-8 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Begelomab Structure]() |
| | Begelomab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Begelomab Usage And Synthesis |
| Uses | Begelomab (SAND-26) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy[1][2]. | | References | [1] Lorenzo RD, et, al. Begelomab for severe refractory dermatomyositis: A case report. Medicine (Baltimore). 2021 Mar 5;100(9):e24372. DOI:10.1097/MD.0000000000024372
[2] Ojha R, et, al. Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2. Hum Immunol. 2022 Apr;83(4):346-355. DOI:10.1016/j.humimm.2022.01.004 |
| | Begelomab Preparation Products And Raw materials |
|